Company · CIK 1710072
Edgewise Therapeutics, Inc.
| CIK | 1710072 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CO |
| Listed | EWTX (Nasdaq) |
| First annual or quarterly report | 2021-05-13 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-279299 | 2024-05-10 | 2025-04-02 | 2 | |
| 333-264083 | 2022-04-01 | 2024-01-19 | 7 | |
| 333-253923 | 2021-03-05 | 2021-03-26 | 5 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-04-02 | 424B5Shelf takedown | 333-279299 | 0001104659-25-031266 |
| 2024-05-10 | S-3ASRShelf registered | 333-279299 | 0001104659-24-059673 |
| 2024-01-19 | 424B5Shelf takedown | 333-264083 | 0001104659-24-005260 |
| 2023-06-16 | 424B5Shelf takedown | 333-264083 | 0001104659-23-072226 |
| 2022-09-14 | 424B5Shelf takedown | 333-264083 | 0001104659-22-100073 |
| 2022-09-13 | 424B5Shelf takedown | 333-264083 | 0001104659-22-099497 |
| 2022-05-05 | EFFECTDeclared effective | 333-264083 | 9999999995-22-001328 |
| 2022-05-05 | 424B5Shelf takedown | 333-264083 | 0001104659-22-056528 |
| 2022-04-01 | S-3Shelf registered | 333-264083 | 0001104659-22-041797 |
| 2021-03-26 | 424B4Final prospectus | 333-253923 | 0001104659-21-042550 |
| 2021-03-25 | EFFECTDeclared effective | 333-253923 | 9999999995-21-001139 |
| 2021-03-24 | S-1/AAmendment | 333-253923 | 0001104659-21-040745 |
| 2021-03-22 | S-1/AAmendment | 333-253923 | 0001104659-21-039429 |
| 2021-03-05 | S-1Registration filed | 333-253923 | 0001104659-21-032712 |
| 2020-12-18 | DRSDraft made public | 377-03916 | 0001104659-20-137501 |